Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients
This retrospective study analyzed 223 azoospermic men with congenital hypogonadotropic hypogonadism (CHH) treated with combined human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG) over a median follow-up of 15 months. Results showed that 64% of patients achieved spermatogenesis, with a median time to sperm appearance of 15 months. Significant